Literature DB >> 10189088

Novel exon skipping mutation in the fibrillin-1 gene: two 'hot spots' for the neonatal Marfan syndrome.

P Booms1, J Cisler, K R Mathews, M Godfrey, F Tiecke, U C Kaufmann, U Vetter, C Hagemeier, P N Robinson.   

Abstract

The Marfan syndrome is an autosomal dominant heritable disorder of connective tissue that involves principally the skeletal, ocular, and cardiovascular systems. The most severe end of the phenotypic spectrum, the neonatal Marfan syndrome (nMFS), is characterized by pronounced atrioventricular valve dysfunction, and death often occurs within the first year of life due to congestive heart failure. Mutations in the gene coding for fibrillin-1, FBN1, are known to cause Marfan syndrome, and have been identified in almost all exons of FBN1. Here, we describe a novel mutation affecting the invariant + 1 position of the splice donor site in intron 31, associated with skipping of exon 31, in a patient with nMFS. Published reports of nMFS are reviewed and a strict definition for nMFS is suggested. If this definition is used, all nMFS mutations reported to date lie in one of two hot spots, comprising mainly missense mutations in FBN1 exons 24-27 and mutations causing skipping of exon 31 or 32.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10189088     DOI: 10.1034/j.1399-0004.1999.550207.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  24 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 2.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 3.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

4.  Two novel mutations of FBN1 in Jordanian patients with Marfan syndrome.

Authors:  Saied A Jaradat; Lama A Abujamous; Ali A Al-Hawamdeh; Khaldoon M Alawneh; Tamara A Rawashdeh; Zaher M Jaradat
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 5.  Variable severity of cardiovascular phenotypes in patients with an early-onset form of Marfan syndrome harboring FBN1 mutations in exons 24-32.

Authors:  Jun Maeda; Kenjiro Kosaki; Junko Shiono; Kazuki Kouno; Ryo Aeba; Hiroyuki Yamagishi
Journal:  Heart Vessels       Date:  2016-01-21       Impact factor: 2.037

6.  Neonatal Marfan Syndrome: Report of a Case with an Inherited Splicing Mutation outside the Neonatal Domain.

Authors:  Laurianne Le Gloan; Quentin Hauet; Albert David; Nadine Hanna; Chloé Arfeuille; Pauline Arnaud; Catherine Boileau; Bénédicte Romefort; Nadir Benbrik; Véronique Gournay; Nicolas Joram; Olivier Baron; Bertrand Isidor
Journal:  Mol Syndromol       Date:  2016-02-02

7.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.

Authors:  L Faivre; G Collod-Beroud; B L Loeys; A Child; C Binquet; E Gautier; B Callewaert; E Arbustini; K Mayer; M Arslan-Kirchner; A Kiotsekoglou; P Comeglio; N Marziliano; H C Dietz; D Halliday; C Beroud; C Bonithon-Kopp; M Claustres; C Muti; H Plauchu; P N Robinson; L C Adès; A Biggin; B Benetts; M Brett; K J Holman; J De Backer; P Coucke; U Francke; A De Paepe; G Jondeau; C Boileau
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

8.  Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome.

Authors:  Jason R Cook; Luca Carta; Ludovic Bénard; Elie R Chemaly; Emily Chiu; Satish K Rao; Thomas G Hampton; Peter Yurchenco; Kevin D Costa; Roger J Hajjar; Francesco Ramirez
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

9.  Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice.

Authors:  Rosanne Rouf; Elena Gallo MacFarlane; Eiki Takimoto; Rahul Chaudhary; Varun Nagpal; Peter P Rainer; Jay G Bindman; Elizabeth E Gerber; Djahida Bedja; Christopher Schiefer; Karen L Miller; Guangshuo Zhu; Loretha Myers; Nuria Amat-Alarcon; Dong I Lee; Norimichi Koitabashi; Daniel P Judge; David A Kass; Harry C Dietz
Journal:  JCI Insight       Date:  2017-08-03

10.  Congenital diaphragmatic eventration and bilateral uretero-hydronephrosis in a patient with neonatal Marfan syndrome caused by a mutation in exon 25 of the FBN1 gene and review of the literature.

Authors:  Nicole Revencu; Geneviève Quenum; Thierry Detaille; Gaston Verellen; Anne De Paepe; Christine Verellen-Dumoulin
Journal:  Eur J Pediatr       Date:  2003-10-30       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.